IVD China last week: Sansure, BGI, Leadman and BD

Sansure Biotech’s Monkeypox virus nucleic acid testing kit approved for market launch

Recently, the Monkeypox Virus Nucleic Acid Testing Kit (PCR-Fluorescent Probe Method) independently developed by Sansure Biotech passed the review of the National Medical Products Administration (NMPA) and was approved for market launch. This marks the tenth Class III medical device registration certificate obtained by Sansure Biotech this year and the first certification for the company’s Disease X solutions for emerging infectious diseases.

Sabin Group, partners with BGI Tech to improve the healthcare and medical standards in Brazil

Recently, Sabin Group, one of Brazil's leading diagnostic and healthcare companies, announced a partnership with BGI Tech. Through this collaboration, both parties aim to improve the accessibility and quality of gene sequencing technology, enhancing healthcare services for the people of Brazil and promoting the benefits of life sciences technology for all. The strong alliance between Sabin Group and BGI Tech will effectively expand the application of advanced gene sequencing technology, enabling personalized diagnosis and treatment for patients, while advancing clinical healthcare standards. 

Leadman and Biolihe officially sign strategic partnership agreement

Leadman and Suzhou Lihe Biotech officially signed a strategic cooperation agreement. 

According to the agreement, both parties, based on the principle of mutual benefit, will engage in in-depth collaboration around the commercialization process of the L1000 fully automated biochemical analyzer in the domestic market. They will leverage their respective advantages in branding, technology, and channels. Through precise market positioning, effective marketing strategies, and professional technical support, the two sides will jointly drive the rapid market penetration of this product series, helping to enhance the market competitiveness and brand influence of domestic medical testing instruments in the IVD industry.

BD's third manufacturing facility in China officially begins operations

BD Medical Technology (Jiangsu) Co., Ltd. grandly opened on December 18, marking the official commencement of operations at BD’s third world-class local manufacturing facility in China. Liu Ying, Vice Mayor of Yixing City, Party Secretary of the Environmental Science Park, and Director of the Management Committee, Eric Borin, Global President of BD Medical’s Medication Delivery Solutions Business, Mo Linyao, Vice President of Integrated Supply Chain for Greater Asia, and Zhu Xueliang, Vice President of Medication Delivery Solutions Business for Greater China, along with other government and corporate leaders, attended the grand opening ceremony to witness this historic moment.